Genetic modifiers of the physical malformations in velo-cardio-facial syndrome/DiGeorge syndrome

Developmental Disabilities Research Reviews

Volumn 14, Issue 1, 2008, Pages 19-25

  Aggarwal, Vimla S ^a   Morrow, Bernice E ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

DiGeorge syndrome; Genetic modifiers; Tbx1; Velo cardio facial syndrome

Indexed keywords

CHORDIN; CRK LIKE PROTEIN; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 8; RETINOIC ACID; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GBX2; TRANSCRIPTION FACTOR PITX2; TRANSCRIPTION FACTOR TBX1; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

CHROMOSOME 22; CHROMOSOME DELETION; DIGEORGE SYNDROME; DNA MODIFICATION; DNA SEQUENCE; GENE INTERACTION; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HETEROZYGOTE; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; VELOCARDIOFACIAL SYNDROME;

EID: 44149086625     PISSN: 19405510     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddrr.4     Document Type: Review

References (60)

1. Abu‐Issa R, Smyth G, Smoak I, et al. 2002. Fgf8 is required for pharyngeal arch and cardiovascular development in the mouse. Development 129: 4613–4625.
2. Aggarwal VS, Liao J, Bondarev A, et al. 2006. Dissection of Tbx1 and Fgf interactions in mouse models of 22q11DS suggests functional redundancy. Hum Mol Genet 15: 3219–3228.
3. Bachiller D, Klingensmith J, Shneyder N, et al. 2003. The role of chordin/Bmp signals in mammalian pharyngeal development and DiGeorge syndrome. Development 130: 3567–3578.
4. Bockman DE, Redmond ME, Kirby ML. 1990. Altered development of pharyngeal arch vessels after neural crest ablation. Ann N Y Acad Sci 588: 296–304.
5. Bockman DE, Redmond ME, Waldo K, Davis H, Kirby ML. 1987. Effect of neural crest ablation on development of the heart and arch arteries in the chick. Am J Anat 180: 332–341.
6. Bottcher RT, Niehrs C. 2005. Fibroblast growth factor signaling during early vertebrate development. Endocr Rev 26: 63–77.
7. Brown CB, Wenning JM, Lu MM, et al. 2004. Cre‐mediated excision of Fgf8 in the Tbx1 expression domain reveals a critical role for Fgf8 in cardiovascular development in the mouse. Dev Biol 267: 190–202.
8. Burn J, Goodship JA. 1996. Congenital heart disease. In: Rimoin DL, Connor JM, Pyeritz RE, editors. Emery and Rimoin's principles and practice of medical genetics, Vol 1. New York: Churchill Livingstone. p 767–828.
9. Byrd NA, Meyers EN. 2005. Loss of Gbx2 results in neural crest cell patterning and pharyngeal arch artery defects in the mouse embryo. Dev Biol 284: 233–245.
10. Chapman DL, Garvey N, Hancock S, et al. 1996. Expression of the T‐box family genes. Tbx1‐Tbx5, during early mouse development. Dev Dyn 206: 379–390.
11. DiGeorge A. 1965. A new concept of the cellular basis of immunity. Disabil Rehabil 67: 907–908.
12. Duester G. 2000. Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur J Biochem 267: 4315–4324.
13. Edelmann L, Pandita RK, Morrow BE. 1999. Low‐copy repeats mediate the common 3‐Mb deletion in patients with velo‐cardio‐facial syndrome. Am J Hum Genet 64: 1076–1086.
14. Ferrara N, Davis‐Smyth T. 1997. The biology of vascular endothelial growth factor. Endocr Rev 18: 4–25.
15. Frank DU, Fotheringham LK, Brewer JA, et al. 2002. An Fgf8 mouse mutant phenocopies human 22q11 deletion syndrome. Development 129: 4591–4603.
16. Fujii H, Sato T, Kaneko S, et al. 1997. Metabolic inactivation of retinoic acid by a novel P450 differentially expressed in developing mouse embryos. EMBO J 16: 4163–4173.
17. Garg V, Yamagishi C, Hu T, et al. 2001. Tbx1, a DiGeorge syndrome candidate gene, is regulated by sonic hedgehog during pharyngeal arch development. Dev Biol 235: 62–73.
18. Graham A. 2003. Development of the pharyngeal arches. Am J Med Genet A 119: 251–256.
19. Guris DL, Duester G, Papaioannou VE, et al. 2006. Dose‐dependent interaction of Tbx1 and Crkl and locally aberrant RA signaling in a model of del22q11 syndrome. Dev Cell 10: 81–92.
20. Guris DL, Fantes J, Tara D, et al. 2001. Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome. Nat Genet 27: 293–298.
21. Hu T, Yamagishi H, Maeda J, et al. 2004. Tbx1 regulates fibroblast growth factors in the anterior heart field through a reinforcing autoregulatory loop involving forkhead transcription factors. Development 131: 5491–5502.
22. Ilagan R, Abu‐Issa R, Brown D, et al. 2006. Fgf8 is required for anterior heart field development. Development 133: 2435–2445.
23. Jerome LA, Papaioannou VE. 2001. DiGeorge syndrome phenotype in mice mutant for the T‐box gene, Tbx1. Nat Genet 27: 286–291.
24. Kelly RG, Brown NA, Buckingham ME. 2001. The arterial pole of the mouse heart forms from Fgf10‐expressing cells in pharyngeal mesoderm. Dev Cell 1: 435–440.
25. Kelly RG, Papaioannou VE. 2007. Visualization of outflow tract development in the absence of Tbx1 using an FgF10 enhancer trap transgene. Dev Dyn 236: 821–828.
26. Kirby ML, Waldo KL. 1995. Neural crest and cardiovascular patterning. Circ Res 77: 211–215.
27. Kobrynski LJ, Sullivan KE. 2007. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 370: 1443–1452. Review.
28. Lindsay EA, Vitelli F, Su H, et al. 2001. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410: 97–101.
29. Macatee TL, Hammond BP, Arenkiel BR, et al. 2003. Ablation of specific expression domains reveals discrete functions of ectoderm‐ and endoderm‐derived FGF8 during cardiovascular and pharyngeal development. Development 130: 6361–6374.
30. Marguerie A, Bajolle F, Zaffran S, et al. 2006. Congenital heart defects in Fgfr2‐IIIb and Fgf10 mutant mice. Cardiovasc Res 71: 50–60.
31. Merscher S, Funke B, Epstein JA, et al. 2001. TBX1 is responsible for cardiovascular defects in velo‐cardio‐facial/DiGeorge syndrome. Cell 104: 619–629.
32. Mjaatvedt CH, Nakaoka T, Moreno‐Rodriguez R, et al. 2001. The outflow tract of the heart is recruited from a novel heart‐forming field. Dev Biol 238: 97–109.
33. Moon AM, Guris DL, Seo JH, et al. 2006. Crkl deficiency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes. Dev Cell 10: 71–80.
34. Nowotschin S, Liao J, Gage PJ, et al. 2006. Tbx1 affects asymmetric cardiac morphogenesis by regulating Pitx2 in the secondary heart field. Development 133: 1565–1573.
35. Park EJ, Ogden LA, Talbot A, et al. 2006. Required, tissue‐specific roles for Fgf8 in outflow tract formation and remodeling. Development 133: 2419–2433.
36. Paylor R, Glaser B, Mupo A, et al. 2006. Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: implications for 22q11 deletion syndrome. Proc Natl Acad Sci USA 103: 7729–7734.
37. Piedra ME, Icardo JM, Albajar M, et al. 1998. Pitx2 participates in the late phase of the pathway controlling left‐right asymmetry. Cell 94: 319–324.
38. Reijntjes S, Gale E, Maden M. 2004. Generating gradients of retinoic acid in the chick embryo: Cyp26C1 expression and a comparative analysis of the Cyp26 enzymes. Dev Dyn 230: 509–517.
39. Roberts C, Ivins S, Cook AC, et al. 2006. Cyp26 genes a1, b1 and c1 are down‐regulated in Tbx1 null mice and inhibition of Cyp26 enzyme function produces a phenocopy of DiGeorge Syndrome in the chick. Hum Mol Genet 15: 3394–3410.
40. Roberts C, Ivins SM, James CT, et al. 2005. Retinoic acid down‐regulates Tbx1 expression in vivo and in vitro. Dev Dyn 232: 928–938.
41. Robin NH, Shprintzen RJ. 2005. Defining the clinical spectrum of deletion 22q11.2. J Pediatr 147: 90–96.
42. Rosa FW, Wilk AL, Kelsey FO. 1986. Teratogen update: vitamin A congeners. Teratology 33: 355–364.
43. Ryan AK, Goodship JA, Wilson DI, et al. 1997. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 34: 798–804.
44. Shaikh TH, Kurahashi H, Saitta SC, et al. 2000. Chromosome 22‐specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. Hum Mol Genet 9: 489–501.
45. Shprintzen RJ, Goldberg RB, Lewin ML, et al. 1978. A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo‐cardio‐facial syndrome. Cleft Palate J 15: 56–62.
46. Stalmans I, Lambrechts D, De Smet F, et al. 2003. VEGF: a modifier of the del22q11 (DiGeorge) syndrome? Nat Med 9: 173–182.
47. Stoller JZ, Epstein JA. 2005. Identification of a novel nuclear localization signal in Tbx1 that is deleted in DiGeorge syndrome patients harboring the 1223delC mutation. Hum Mol Genet 14: 885–892.
48. Taddei I, Morishima M, Huynh T, et al. 2001. Genetic factors are major determinants of phenotypic variability in a mouse model of the DiGeorge/del22q11 syndromes. Proc Natl Acad Sci USA 98: 11428–11431.
49. Vermot J, Niederreither K, Garnier JM, et al. 2003. Decreased embryonic retinoic acid synthesis results in a DiGeorge syndrome phenotype in newborn mice. Proc Natl Acad Sci USA 100: 1763–1768.
50. Vitelli F, Taddei I, Morishima M, et al. 2002. A genetic link between Tbx1 and fibroblast growth factor signaling. Development 129: 4605–4611.
51. Vitelli F, Zhang Z, Huynh T, et al. 2006. Fgf8 expression in the Tbx1 domain causes skeletal abnormalities and modifies the aortic arch but not the outflow tract phenotype of Tbx1 mutants. Dev Biol 295: 559–570.
52. Waldo KL, Kumiski DH, Wallis KT, et al. 2001. Conotruncal myocardium arises from a secondary heart field. Development 128: 3179–3188.
53. Washington Smoak I, Byrd NA, Abu‐Issa R, et al. 2005. Sonic hedgehog is required for cardiac outflow tract and neural crest cell development. Dev Biol 283: 357–372.
54. Wassarman KM, Lewandoski M, Campbell K, et al. 1997. Specification of the anterior hindbrain and establishment of a normal mid/hindbrain organizer is dependent on Gbx2 gene function. Development 124: 2923–2934.
55. Wurdak H, Ittner LM, Lang KS, et al. 2005. Inactivation of TGFbeta signaling in neural crest stem cells leads to multiple defects reminiscent of DiGeorge syndrome. Genes Dev 19: 530–535.
56. Xu H, Morishima M, Wylie JN, et al. 2004. Tbx1 has a dual role in the morphogenesis of the cardiac outflow tract. Development 131: 3217–3227.
57. Yagi H, Furutani Y, Hamada H, et al. 2003. Role of TBX1 in human del22q11.2 syndrome. Lancet 362: 1366–1373.
58. Yamagishi H, Maeda J, Hu T, et al. 2003. Tbx1 is regulated by tissue‐specific forkhead proteins through a common sonic hedgehog‐responsive enhancer. Genes Dev 17: 269–281.
59. Zhang L, Zhong T, Wang Y, et al. 2006. TBX1, a DiGeorge syndrome candidate gene, is inhibited by retinoic acid. Int J Dev Biol 50: 55–61.
60. Zhang Z, Cerrato F, Xu H, et al. 2005. Tbx1 expression in pharyngeal epithelia is necessary for pharyngeal arch artery development. Development 132: 5307–5315.